Literature DB >> 7112685

A diffusion chamber technique for detecting compounds with clinical prophylactic activity against Brugia pahangi.

J P Court.   

Abstract

A new technique for examining the clinical prophylactic activity of antifilarial agents against Brugia pahangi is described. Third stage larvae were confined within diffusion chambers before intraperitoneal implantation into jirds. Such larvae developed normally within the chambers for 14 days when compared with infections in which larvae were allowed to grow freely within the peritoneal cavity. After this time conditions inside the chambers deteriorated and larval growth was inhibited. Larval recoveries from diffusion chambers after 14 days were higher and more reproducible than from intraperitoneal infections. The activities of known antifilarial agents against larvae confined within chambers implanted into jirds were examined. The benzimidazoles were found to be extremely effective Flubendazole killed almost all larvae when administered at 5 x 25 mg/kg sc by day 9 after the final treatment. It is suggested that the test described has potential as a screen for detecting clinical prophylactic activity because of its reproducibility, low parasite requirement, ease of parasite recovery and relatively short result acquisition time.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7112685

Source DB:  PubMed          Journal:  Tropenmed Parasitol        ISSN: 0303-4208


  2 in total

1.  Morphological demonstration of essential functional changes after in vitro and in vivo transition of infective Onchocerca volvulus to the post-infective stage.

Authors:  G Strote; I Bonow
Journal:  Parasitol Res       Date:  1991       Impact factor: 2.289

2.  UMF-078: A modified flubendazole with potent macrofilaricidal activity against Onchocerca ochengi in African cattle.

Authors:  Barend M Dec Bronsvoort; Benjamin L Makepeace; Alfons Renz; Vincent N Tanya; Lawrence Fleckenstein; David Ekale; Alexander J Trees
Journal:  Parasit Vectors       Date:  2008-06-20       Impact factor: 3.876

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.